Skip to content

Do Generic Volar Locking Plates Provide Similar Outcomes at a Reduced Cost?

Generic Volar Locking Plate Use in Distal Radius Fractures: A Prospective Randomized Study to Evaluate Clinical Outcomes and Cost Reduction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06343467
Enrollment
101
Registered
2024-04-02
Start date
2022-11-01
Completion date
2023-04-30
Last updated
2024-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Distal Radius Fractures

Keywords

Volar Locking Plate, Generic Implants

Brief summary

Across orthopedics, the investigators will be using the generic volar locking plates for patients undergoing open reduction and internal fixation (ORIF) of the distal radius using a block schedule, meaning one month we the generic implants and one month we use conventional implants from the surgeon's brand of choice. At the end of each month the health system will switch which type of implants (generic vs. conventional) they will use at their facilities. From a quality perspective each patient will be monitored both short and long term for complication and reoperation. This will be done through chart review.

Detailed description

Patients will be consented to surgery per a standard surgical consent form. Six surgeons who regularly perform distal radius fracture (DRF) ORIF are included (five hand and one orthopaedic trauma fellowship-trained). Per the practice protocol, patients will either be treated with a generic plate or a brand name plate as described above. Ultimately, the decision to use a generic volar locking plate (VLP) is left up to surgeon discretion. All surgical and follow-up data will be collected. Implants used, age at time of surgery, weight, height, gender, race, ethnicity, comorbidities (diabetes, heart disease, etc.), complications including, but not limited to: readmission, reoperation, non-union, wound dehiscence, and lab tests will be collected. This will be evaluated all within 90 days following surgery. Implants will be cross referenced with the institution's data base to determine cost. All data will be collected on a secure server and be kept password protected. The primary outcome was 90-day postoperative complications (readmissions, reoperations, and mortality rates) by implant vendor type (generic vs. conventional). Secondary outcomes consisted of implant costs, estimated blood loss, and tourniquet time. An a priori power analysis was conducted to estimate the minimum sample size needed to adequately detect a difference in reoperation rates with a large effect size (Cohen's d=0.8). At a Type I error rate of 0.05, a power of 80%, and a 1:1 group allocation, the estimated sample size was 36 patients (18 generic VLPs vs. 18 conventional VLPs). Statistical significance was set to p≤0.05.

Interventions

DEVICEGeneric Volar Locking Plate

Application of a generic volar locking plate is done in the generic implant arm compared to the other commonly used implants by surgeons in the conventional implant arm.

DEVICEConventional Volar Locking Plate

Application of a conventional, brand name volar locking plate is done in the conventional implant arm compared to the generic implant arm.

Sponsors

HealthPartners Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients underwent the standard surgical consent, however the specific plate vendor that was used, was not specified by the physician.

Intervention model description

Surgeons alternated between using generic implants and conventional implants in their distal radius fracture patients over the course of six months.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Isolated distal radius fracture * Treated surgically with a volar locking plate

Exclusion criteria

* Volar locking plate not used * Additional fixation was used * Polytrauma (non-isolated injury) * Open fracture * \<18 years old

Design outcomes

Primary

MeasureTime frameDescription
90-day Reoperation RateWithin 90 days postoperativelyReoperation for any reason postoperatively within 90 days after the date of surgery.
90-day Readmission RateWithin 90 days postoperativelyReadmission to the hospital for any reason postoperatively within 90 days after the date of surgery.
90-day Mortality RateWithin 90 days postoperativelyPatient death at any point within 90 days after the date of surgery.

Secondary

MeasureTime frameDescription
Implant CostDay of SurgeryThe total cost of implants used in the procedure, including screws, pegs, volar locking plates, and disposable implants.
Tourniquet TimeFrom tourniquet inflation to deflation during the procedure.The total time in minutes from tourniquet inflation to deflation for a surgical case.
Estimated Blood LossDay of SurgeryEstimated blood loss for the surgical case as reported by the surgeon in milliliters.

Countries

United States

Participant flow

Pre-assignment details

Detailed physical examination of patient with radiographic evaluation of distal radius fracture and indication for volar locking plate open reduction and internal fixation. Patients with open fracture observed on physical examination, polytrauma (any other fracture or medical instability), metaphyseal extension of the fracture, age less than 18 years, and fracture pattern not suitable for fixation with volar locking plate were excluded before assignment to groups.

Participants by arm

ArmCount
Generic Implant
Patients with an isolated distal radius fracture are treated surgically with a generic volar locking plate. All other surgical protocols remain unchanged. Generic Volar Locking Plate: Application of a generic volar locking plate is done in the generic implant arm compared to the other commonly used implants by surgeons in the conventional implant arm.
19
Conventional Implant
Patients with an isolated distal radius fracture are treated surgically with a conventional, brand name volar locking plate of the surgeon's choice. All other surgical protocols remain unchanged. Conventional Volar Locking Plate: Application of a conventional, brand name volar locking plate is done in the conventional implant arm compared to the generic implant arm.
47
Total66

Baseline characteristics

CharacteristicConventional ImplantTotalGeneric Implant
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
20 Participants26 Participants6 Participants
Age, Categorical
Between 18 and 65 years
27 Participants40 Participants13 Participants
Age, Continuous60.74 years
STANDARD_DEVIATION 11.37
61.03 years
STANDARD_DEVIATION 11.52
61.75 years
STANDARD_DEVIATION 12.16
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
47 Participants66 Participants19 Participants
Sex: Female, Male
Female
43 Participants61 Participants18 Participants
Sex: Female, Male
Male
4 Participants5 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 47
other
Total, other adverse events
0 / 190 / 47
serious
Total, serious adverse events
0 / 190 / 47

Outcome results

Primary

90-day Mortality Rate

Patient death at any point within 90 days after the date of surgery.

Time frame: Within 90 days postoperatively

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Generic Implant90-day Mortality Rate0 Participants
Conventional Implant90-day Mortality Rate0 Participants
Primary

90-day Readmission Rate

Readmission to the hospital for any reason postoperatively within 90 days after the date of surgery.

Time frame: Within 90 days postoperatively

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Generic Implant90-day Readmission Rate0 Participants
Conventional Implant90-day Readmission Rate0 Participants
Primary

90-day Reoperation Rate

Reoperation for any reason postoperatively within 90 days after the date of surgery.

Time frame: Within 90 days postoperatively

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Generic Implant90-day Reoperation Rate0 Participants
Conventional Implant90-day Reoperation Rate0 Participants
Secondary

Estimated Blood Loss

Estimated blood loss for the surgical case as reported by the surgeon in milliliters.

Time frame: Day of Surgery

ArmMeasureValue (MEAN)Dispersion
Generic ImplantEstimated Blood Loss13.3 millilitersStandard Deviation 10.2
Conventional ImplantEstimated Blood Loss13.2 millilitersStandard Deviation 6.8
Secondary

Implant Cost

The total cost of implants used in the procedure, including screws, pegs, volar locking plates, and disposable implants.

Time frame: Day of Surgery

ArmMeasureValue (MEAN)Dispersion
Generic ImplantImplant Cost702.38 United States DollarsStandard Deviation 47.83
Conventional ImplantImplant Cost1348.61 United States DollarsStandard Deviation 100.77
Secondary

Tourniquet Time

The total time in minutes from tourniquet inflation to deflation for a surgical case.

Time frame: From tourniquet inflation to deflation during the procedure.

ArmMeasureValue (MEAN)Dispersion
Generic ImplantTourniquet Time49.05 minutesStandard Deviation 19.2
Conventional ImplantTourniquet Time45.06 minutesStandard Deviation 12.84

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026